NASDAQ : DAVI

Davion Healthcare Plc — Key statistics

Healthcare · Medical Devices · Ireland

Last price 1.68 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 42.00M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Key statistics

Valuation

MeasureValue
Market Cap37.25M
Enterprise Value38.31M

Dates

MeasureValue
Earnings DateApr 6, 2027
Ex-Dividend Daten/a

Shares

MeasureValue
Current Share Class25.00M
Shares Outstanding25.00M
Shares Change (YoY)+9.12%
Shares Change (QoQ)n/a
Owned by Insiders (%)87.16%
Owned by Institutions (%)n/a
Float3.21M

Ratios

MeasureValue
PE Ration/a
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ratio0.49
P/TBV Ration/a
P/FCF Ration/a
P/OCF Ration/a
PEG Ration/a

Evratios

MeasureValue
EV / Earningsn/a
EV / Salesn/a
EV / EBITDAn/a
EV / EBITn/a
EV / FCFn/a

Financialposition

MeasureValue
Current Ratio1.59
Quick Ratio0.20
Debt / Equity0.01
Debt / EBITDAn/a
Debt / FCFn/a
Interest Coveragen/a

Financialefficiency

MeasureValue
Return on Equity (ROE)-1.28%
Return on Assets (ROA)-0.79%
Return on Invested Capital (ROIC)-0.79%
Return on Capital Employed (ROCE)-1.27%
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employeen/a
Employee Countn/a
Asset Turnovern/a
Inventory Turnovern/a

Taxes

MeasureValue
Income Taxn/a
Effective Tax Raten/a

Stockprice

MeasureValue
Beta (5Y)n/a
52-Week Price Changen/a
50-Day Moving Averagen/a
200-Day Moving Averagen/a
Relative Strength Index (RSI)n/a
Average Volume (20 Days)2,750,267

Shortselling

MeasureValue
Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Incomestatement

MeasureValue
Revenuen/a
Gross Profitn/a
Operating Income-967,450
Pretax Income-967,450
Net Income-967,450
EBITDAn/a
EBIT-967,450
Earnings Per Share (EPS)-$0.04

Balancesheet

MeasureValue
Cash & Cash Equivalents1,242
Total Debt1.07M
Net Cash-1.06M
Net Cash Per Share-$0.04
Equity (Book Value)75.31M
Book Value Per Share3.01
Working Capital61,157

Cashflow

MeasureValue
Operating Cash Flow-361
Capital Expendituresn/a
Depreciation & Amortizationn/a
Net Borrowing1,533
Free Cash Flown/a
FCF Per Sharen/a

Margins

MeasureValue
Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends

MeasureValue
Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
FCF Payout Ration/a
Buyback Yield-9.12%
Shareholder Yield-9.12%
Earnings Yield-2.60%
FCF Yieldn/a

Analystforecasts

MeasureValue
Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Stocksplits

MeasureValue
Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

MeasureValue
Altman Z-Scoren/a
Piotroski F-Score2

Fairvalue

MeasureValue
Lynch Fair Valuen/a
Lynch Upsiden/a
Graham Numbern/a
Graham Upsiden/a